At North Quest Solutions, we provide comprehensive Medical Writing and Reporting Solutions to support Contract Research Organizations (CROs), pharmaceutical companies, biotechnology firms, medical device manufacturers, and research institutions across the United States.
Our experienced medical writers develop high-quality, scientifically accurate, and regulatory-compliant documents that support every stage of the clinical development lifecycle. From protocol development and regulatory submissions to Clinical Study Reports (CSRs) and safety narratives, we ensure every document meets the highest standards of quality, clarity, and compliance with FDA, EMA, ICH-GCP, and global regulatory guidelines.
Our team collaborates closely with sponsors, clinical operations teams, medical monitors, biostatisticians, and regulatory affairs professionals to deliver documentation that accelerates clinical development while maintaining scientific integrity and regulatory compliance.
We provide end-to-end medical writing support, including:
Our medical writing professionals combine scientific expertise with extensive regulatory knowledge to deliver clear, accurate, and submission-ready documentation that supports successful clinical research programs.
We are committed to delivering:
Our Medical Writing and Reporting Solutions are designed for:
Every document undergoes a rigorous quality review process to ensure scientific accuracy, consistency, regulatory compliance, and readiness for submission. Our team follows industry best practices and global regulatory standards to help clients reduce review cycles, improve documentation quality, and accelerate clinical development timelines.
Whether you need support for a single regulatory document or complete medical writing services throughout the clinical development process, North Quest Solutions is your trusted partner for reliable, high-quality, and compliant medical writing solutions.
Our experts are dedicated to helping life sciences organizations deliver accurate documentation, streamline regulatory submissions, and successfully advance clinical research programs.